doi: 10.1093/nar/gkae973 Summary Keywords atheroscelrosis, cholesterol metabolism, acetyl-L-carnitine (ALC), SREBP2, HMGCR Citation Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X, Han L, Sun X, Sun H, Du Y, Hu C, Yu H and Qin Y (2024) Acetyl-L-carnitine ameliorates atherosclerosis in LDLR / mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis
It is a long-acting analog of Growth Hormone-Releasing Hormone (GHRH), widely used in peptide therapy to support fitness, anti-aging, and overall wellness goals
By acting as a pioneer in new markets and developing innovative products, we are aiming to grow as a company that fulfills its responsibilities in the global health sector. by Joo-kyung Cha ([email protected])
Medical compounding solution